Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease

Area of Science:

• Cardiovascular Science
• Hematology
• Nutritional Science

Background:

• Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
• Platelet adhesion is a critical early event in the development and progression of CVD.
• Vitamin E is recognized for its potential role in managing cardiovascular health.

Purpose of the Study:

• To elucidate the mechanism by which Vitamin E inhibits platelet function.
• To investigate the role of Vitamin E in preventing cardiovascular disease.
• To assess the clinical implications of Vitamin E's effects on platelets.

Main Methods:

• Investigated the effect of Vitamin E on platelet adhesion.
• Examined the mechanism of Vitamin E's action on platelet function, focusing on protein kinase C (PKC).
• Analyzed the impact of Vitamin E in conjunction with platelet aggregation inhibitors.

Main Results:

• Vitamin E significantly inhibits platelet adhesion, a key factor in cardiovascular disease.
• This inhibition is mediated by Vitamin E's suppression of protein kinase C (PKC), independent of its antioxidant activity.
• Vitamin E reduces agonist-induced platelet pseudopodia formation, thereby decreasing adhesion.
• Combination therapy with Vitamin E and potent platelet aggregation inhibitors increases bleeding risk.

Conclusions:

• Vitamin E offers significant benefits in preventing and inhibiting cardiovascular disease.
• Its mechanism involves PKC inhibition, reducing platelet adhesion independently of antioxidant effects.
• While increased bleeding is a potential side effect, the benefits of Vitamin E for cardiovascular health are substantial for most patients.